Plain-English translation of NCT06014723 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial tests whether a procedure called submaximal balloon angioplasty, when done early after a minor stroke, works better than medication alone. The procedure gently widens narrowed blood vessels in the brain that are causing strokes. Researchers will follow 416 patients for one year to see if this combined approach prevents future strokes better than medication by itself.
Many patients who have minor strokes from narrowed brain blood vessels go on to have more strokes despite taking medication. This study is trying to find out whether adding an early balloon procedure to standard medical care can better protect patients from future strokes.
You likely qualify if…
You likely don't qualify if…
If you qualify and agree to join, you will be randomly assigned to receive either the balloon procedure plus medication or medication alone. You will have visits at multiple study centers in China over the course of one year, where doctors will monitor you for any complications and check whether you have had another stroke. The study tracks your recovery and safety to compare how well each approach works.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
China
Sponsor
Shouchun Wang, MD, PhD
Collaborators
The General Hospital of Northern Theater Command
Enrollment target
~416 participants
Started
August 2023
Primary completion
September 2026
Age range
30 Years – 80 Years
Last updated on clinicaltrials.gov in January 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shouchun Wang, MD, PhD
Shouchun Wang, MD, PhD
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.